147 related articles for article (PubMed ID: 36922769)
1. Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target.
Djiyou ABD; Penda CI; Madec Y; Ngondi GD; Moukoko A; Varloteaux M; de Monteynard LA; Moins C; Moukoko CEE; Aghokeng AF
BMC Pediatr; 2023 Mar; 23(1):119. PubMed ID: 36922769
[TBL] [Abstract][Full Text] [Related]
2. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat".
Fokam J; Sosso SM; Yagai B; Billong SC; Djubgang Mbadie RE; Kamgaing Simo R; Edimo SV; Nka AD; Tiga Ayissi A; Yimga JF; Takou D; Moudourou S; Ngo Nemb M; Nfetam Elat JB; Santoro MM; Perno CF; Colizzi V; Ndjolo A
AIDS Res Ther; 2019 Nov; 16(1):36. PubMed ID: 31744517
[TBL] [Abstract][Full Text] [Related]
3. Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.
Ntombela NP; Kharsany ABM; Soogun A; Yende-Zuma N; Baxter C; Kohler HP; McKinnon LR
Reprod Health; 2022 May; 19(1):116. PubMed ID: 35550580
[TBL] [Abstract][Full Text] [Related]
4. High risk of virologic failure among HIV-infected children and adolescents routinely followed-up in Littoral region of Cameroon.
Mbébi Enoné PJ; Penda CI; Ngondi G; Fokam J; Ebong SB; Mekoulou Ndongo J; Essangui Same EG; Ndjengue Nson LS; Mandengue SH; Eboumbou Moukoko CE
PLoS One; 2023; 18(8):e0289426. PubMed ID: 37561800
[TBL] [Abstract][Full Text] [Related]
5. Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon.
Penda CI; Moukoko Mbonjo M; Fokam J; Djeuda ABD; Grace N; Ateba Ndongo F; Bilong S; Eyoum Bille B; Koki Ndombo P; Aghokeng A; Ndjolo A; Eboumbou Moukoko CE
PLoS One; 2022; 17(10):e0276730. PubMed ID: 36288365
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
[TBL] [Abstract][Full Text] [Related]
8. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.
Fokam J; Billong SC; Jogue F; Moyo Tetang Ndiang S; Nga Motaze AC; Paul KN; Njom Nlend AE
PLoS One; 2017; 12(11):e0187566. PubMed ID: 29112991
[TBL] [Abstract][Full Text] [Related]
9. Viral suppression among adolescents on HIV treatment in the Sedibeng District, Gauteng province.
Mabizela S; Van Wyk B
Curationis; 2022 Sep; 45(1):e1-e8. PubMed ID: 36226955
[TBL] [Abstract][Full Text] [Related]
10. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.
Njom-Nlend AE; Efouba N; Brunelle Sandie A; Fokam J
Trop Med Int Health; 2021 Aug; 26(8):927-935. PubMed ID: 33905593
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
[TBL] [Abstract][Full Text] [Related]
12. Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J; Takou D; Njume D; Pabo W; Santoro MM; Njom Nlend AE; Beloumou G; Sosso S; Moudourou S; Teto G; Dambaya B; Djupsa S; Tetang Ndiang S; Ateba FN; Billong SC; Kamta C; Bala L; Lambo V; Tala V; Chenwi Ambe C; Mpouel ML; Cappelli G; Cham F; Ndip R; Mbuagbaw L; Koki Ndombo P; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2021 Aug; 22(7):567-580. PubMed ID: 33792134
[TBL] [Abstract][Full Text] [Related]
13. Determinants of viral suppression among adolescents on antiretroviral treatment in Ehlanzeni district, South Africa: a cross-sectional analysis.
Okonji EF; van Wyk B; Mukumbang FC; Hughes GD
AIDS Res Ther; 2021 Oct; 18(1):66. PubMed ID: 34627300
[TBL] [Abstract][Full Text] [Related]
14. Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.
Fokam J; Nangmo A; Wandum C; Takou D; Santoro MM; Nlend AN; Ateba FN; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Lambo V; Fokunang C; Mbanya D; Colizzi V; Perno CF; Ndjolo A
AIDS Res Ther; 2020 May; 17(1):14. PubMed ID: 32398107
[TBL] [Abstract][Full Text] [Related]
15. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).
Liégeois F; Eymard-Duvernay S; Boyer S; Maradan G; Kouanfack C; Domyeum J; Boyer V; Mpoudi-Ngolé E; Spire B; Delaporte E; Vidal L; Kuaban C; Laurent C;
HIV Med; 2019 Jan; 20(1):38-46. PubMed ID: 30362279
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies.
Ka'e AC; Nanfack AJ; Ambada G; Santoro MM; Takou D; Semengue ENJ; Nka AD; Bala MLM; Endougou ON; Elong E; Beloumou G; Djupsa S; Gouissi DH; Fainguem N; Tchouaket MCT; Sosso SM; Kesseng D; Ndongo FA; Sonela N; Kamta ACL; Tchidjou HK; Ndomgue T; Ndiang STM; Nlend AEN; Nkenfou CN; Montesano C; Halle-Ekane GE; Cappelli G; Tiemessen CT; Colizzi V; Ceccherini-Silberstein F; Perno CF; Fokam J
Front Immunol; 2023; 14():1239877. PubMed ID: 37646023
[TBL] [Abstract][Full Text] [Related]
18. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR; Fokam J; Njume D; Takou D; Santoro MM; Nyasa RB; Chenwi C; Mpouel ML; Beloumou G; Jagni ESN; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Gouissi Anguechia DH; Evariste M; Kamta C; Bala L; Lambo V; Halle-Ekane EG; Colizzi V; Perno CF; Ndjolo A; Ndip Ndip R
PLoS One; 2023; 18(10):e0293326. PubMed ID: 37878637
[TBL] [Abstract][Full Text] [Related]
20. Progress towards the UNAIDS 95-95-95 targets among pregnant women in South Africa: Results from the 2017 and 2019 national Antenatal HIV Sentinel Surveys.
Woldesenbet S; Cheyip M; Lombard C; Manda S; Ayalew K; Kufa T; Puren A
PLoS One; 2022; 17(7):e0271564. PubMed ID: 35862306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
